Literature DB >> 12866944

Colonic drug delivery: an updated review.

M Ajmal Shareef1, Roop K Khar, Alka Ahuja, Farhan Jalees Ahmad, Swita Raghava.   

Abstract

Specific targeting of drug to the colon is recognized to have several therapeutic advantages. Drugs that are destroyed by the acidic environment of the stomach or metabolized by pancreatic enzymes are only slightly affected in the colon. Sustained colonic delivery of drugs can be useful in the treatment of nocturnal asthma, angina, and arthritis. Treatment of colonic diseases such as ulcerative colitis, Crohn's disease, and colorectal cancer is more effective with direct delivery of drugs to the colon. This article is aimed at providing insight into the design considerations and evaluation of colonic drug delivery systems. The anatomy and physiology of the lower gastrointestinal tract is discussed; then the biopharmaceutical aspects are considered in relation to drug absorption in the colon. Various approaches to colon-specific drug delivery are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12866944     DOI: 10.1208/ps050217

Source DB:  PubMed          Journal:  AAPS PharmSci        ISSN: 1522-1059


  6 in total

1.  Fluid replacement via the rectum for treatment of hypovolaemic shock in an animal model.

Authors:  A S Girisgin; F Acar; B Cander; M Gul; S Kocak; S Bodur
Journal:  Emerg Med J       Date:  2006-11       Impact factor: 2.740

2.  Influence of food intake on the bioavailability and efficacy of oral calcitonin.

Authors:  Morten A Karsdal; Inger Byrjalsen; Möise Azria; Michel Arnold; Les Choi; Bente J Riis; Claus Christiansen
Journal:  Br J Clin Pharmacol       Date:  2009-04       Impact factor: 4.335

Review 3.  Lessons learned from the clinical development of oral peptides.

Authors:  Morten Asser Karsdal; Bente Juul Riis; Nozer Mehta; William Stern; Ehud Arbit; Claus Christiansen; Kim Henriksen
Journal:  Br J Clin Pharmacol       Date:  2015-05       Impact factor: 4.335

4.  Enteric coated magnetic HPMC capsules evaluated in human gastrointestinal tract by AC biosusceptometry.

Authors:  Luciana A Corá; Fernando G Romeiro; Fabiano C Paixão; Madileine F Américo; Ricardo B Oliveira; Oswaldo Baffa; José Ricardo A Miranda
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

5.  Optimizing bioavailability of oral administration of small peptides through pharmacokinetic and pharmacodynamic parameters: the effect of water and timing of meal intake on oral delivery of Salmon Calcitonin.

Authors:  Morten A Karsdal; Inger Byrjalsen; Bente J Riis; Claus Christiansen
Journal:  BMC Clin Pharmacol       Date:  2008-09-09

6.  Investigation of the diurnal variation in bone resorption for optimal drug delivery and efficacy in osteoporosis with oral calcitonin.

Authors:  M A Karsdal; I Byrjalsen; B J Riis; C Christiansen
Journal:  BMC Clin Pharmacol       Date:  2008-12-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.